Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lorazepam
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lorazepam 1mg tablets
0401020P0AAABAB
|
Lorazepam | Lorazepam | Central Nervous System | 121,829 |
|
Lorazepam 500microgram tablets
0401020P0AAADAD
|
Lorazepam | Lorazepam | Central Nervous System | 42,743 |
|
Lorazepam 2.5mg tablets
0401020P0AAACAC
|
Lorazepam | Lorazepam | Central Nervous System | 5,981 |
|
Lorazepam 1mg/ml oral solution sugar free
0401020P0AACICI
|
Lorazepam | Lorazepam | Central Nervous System | 2,595 |
|
Lorazepam 250microgram tablets
0401020P0AACMCM
|
Lorazepam | Lorazepam | Central Nervous System | 2,332 |
|
Lorazepam 1mg/5ml oral solution
0401020P0AACDCD
|
Lorazepam | Lorazepam | Central Nervous System | 155 |
|
Lorazepam 500micrograms/5ml oral solution
0401020P0AACFCF
|
Lorazepam | Lorazepam | Central Nervous System | 139 |
|
Lorazepam 1mg/5ml oral suspension
0401020P0AACECE
|
Lorazepam | Lorazepam | Central Nervous System | 46 |
|
Lorazepam 1mg orodispersible tablets
0401020P0AACKCK
|
Lorazepam | Lorazepam | Central Nervous System | 40 |
|
Lorazepam 4mg/1ml solution for injection ampoules
0401020P0AAAAAA
|
Lorazepam | Lorazepam | Central Nervous System | 35 |
|
Lorazepam 500micrograms/5ml oral suspension
0401020P0AACGCG
|
Lorazepam | Lorazepam | Central Nervous System | 30 |
|
Lorazepam 5mg/5ml oral liquid
0401020P0AABJBJ
|
Lorazepam | Lorazepam | Central Nervous System | 10 |
|
Lorazepam 250micrograms/5ml oral liquid
0401020P0AABHBH
|
Lorazepam | Lorazepam | Central Nervous System | 9 |
|
Ativan 4mg/1ml solution for injection ampoules
0401020P0BCAAAA
|
Ativan | Lorazepam | Central Nervous System | 6 |
|
Lorazepam 1.125mg/5ml oral liquid
0401020P0AACACA
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 2.5mg orodispersible tablets
0401020P0AACLCL
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 2mg/1ml solution for injection ampoules
0401020P0AACHCH
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 2mg/1ml solution for injection vials
0401020P0AACJCJ
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 2mg/5ml oral liquid
0401020P0AABRBR
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 3.75mg/5ml oral liquid
0401020P0AABZBZ
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 400micrograms/5ml oral liquid
0401020P0AABSBS
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 4mg/5ml oral liquid
0401020P0AABXBX
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.